Traveling with Medical Marijuana

The number of patients with an active prescription for medical marijuana in Poland exceeded 130,000 in 2025, according to data from the National Bureau for Counteracting Addiction (KCPU, 2025). With the increase in the number of treated patients, a practical question arises. How can one legally travel with a medication containing THC within Europe and beyond?

International legal frameworks create three pillars: the Single Convention on Narcotic Drugs of 1961, the Schengen Executive Convention (Article 75) of 1985, and national laws implementing these treaties. In practice, a patient from Poland can carry a 30-day supply of medication within the Schengen area if they have a certificate validated by the Provincial Pharmaceutical Inspector.

This guide covers specific procedures, friendly and restrictive countries, documentation from Polish pharmacies, and border control scenarios. The data comes from ISAP, EMCDDA, INCB reports, IATA Travel Centre, and official communications from the Polish embassies. It has been updated as of April 2026, taking into account the German CanG reform of 2024 and the Czech liberalization of 2025.

KEY INFORMATION
– The Schengen certificate under Article 75 is valid for a maximum of 30 days and covers only stays in 29 countries of the zone (ISAP, Journal of Laws 2007 No. 120 item 818).
– A Polish prescription for THC flower or extract is not honored outside the EU, including in the USA, UAE, and Japan (INCB Annual Report, 2024).
– Translations of documents into English are not sufficient in countries requiring certified legalization (e.g., France, Italy).
– Patient-friendly countries in 2026: Germany, Netherlands, Czech Republic, Spain, Portugal, Austria.
– Restrictive countries (zero tolerance): UAE, Singapore, Japan, Indonesia, Egypt, Turkey, Saudi Arabia.

What international conventions regulate the transport of medical marijuana?

Three UN treaties create a global legal framework: the Single Convention on Narcotic Drugs of March 30, 1961, the Convention on Psychotropic Substances of February 21, 1971, and the Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of December 20, 1988. All 186 states parties place THC in Schedule I as a substance under strict control (INCB Annual Report, 2024).

Poland has ratified all three conventions. The national implementation is the Act of July 29, 2005, on counteracting drug addiction (ISAP, Dz.U. 2005 Nr 179 poz. 1485). Cannabis flower and its extracts containing more than 0.3% THC are listed in group I-N. At the same time, the law provides an exception for medical uses following the amendment of November 1, 2017.

Schengen Executive Convention, Article 75

Article 75 of the Executive Convention of June 19, 1990 (EUR-Lex, document 42000A0922(02)) allows patients to transport narcotic drugs for personal treatment within the Schengen area. The condition is to have a certificate issued by the competent authority of the country of residence. In Poland, this is done by the Provincial Pharmaceutical Inspector at the request of the attending physician.

The certificate has a uniform format for all 29 Schengen countries. It includes the patient's data, the name and quantity of the medication, dosage, and validity period. The latter cannot exceed 30 days from the date of issuance. Each certificate covers one trip, even if the patient visits several countries along the way.

The Single Convention of 1961 – what does it mean for the patient?

The 1961 Convention requires states to control the production, distribution, and cross-border flow of narcotic drugs. Annex I includes cannabis and extracts containing THC. The UN Commission on Narcotic Drugs removed cannabis from the most restrictive Schedule IV in December 2020 but left it in Schedule I (UNODC, 2020).

The 2020 decision opened the way for medical research but did not abolish the requirement for permits when transporting internationally. A patient transporting medication between countries outside Schengen must obtain an import permit from the destination country and an export permit from the country of departure. The procedure usually takes 4-8 weeks.

Article 75 of the Schengen Executive Convention of June 19, 1990, allows patients to transport narcotic drugs for personal use within the 29 countries of the area, based on a certificate valid for a maximum of 30 days and issued by the competent authority of the country of residence (EUR-Lex, document 42000A0922(02)).

What documents from Poland do you need for traveling with medical marijuana?

The complete set of documents includes four mandatory elements: Schengen certificate under Article 75, original prescription from the pharmacy, medical documentation with a diagnosis, and a sworn translation into English. According to a study by the Polish Association of Medical Marijuana Patients (PSPMM, 2025), about 73% of patients report problems with completing documents on time, mainly due to long waiting times at the Provincial Pharmaceutical Inspector.

The procedure starts at least 6 weeks before departure. The patient asks the attending physician for a request to issue a certificate. The physician fills out the form and submits it to the Provincial Pharmaceutical Inspector relevant to the patient's place of residence. After positive verification, the office issues a certificate in accordance with the Schengen format.

Certificate from the Provincial Pharmaceutical Inspector

The certificate contains the patient's data from the identity document, the name of the medication according to the prescription, the quantity in grams, the daily dose, the travel period, and the date of issue. The form has been uniform in the EU since the Commission's implementing decision 2018/1581. The maximum validity is 30 days from the date of issuance, not 30 days of stay (EUR-Lex, 2018).

Practical consequence: if you are leaving for 4 weeks but plan to depart in 3 weeks from today, the certificate issued today will only be valid for one week of stay. In such a case, ask for a document to be issued with a date closer to the departure.

Prescription and medical documentation

A prescription for THC flower or extract in Poland takes the form of Rpw (prescription for narcotic drugs). It is issued by a physician authorized to prescribe medical marijuana. The prescription is valid for 14 days from the date of issuance, so the patient fills it at the pharmacy just before departure. The medication is dispensed in the original pharmacy packaging, with a label bearing the patient's name.

Medical documentation should include an information card with a diagnosis (ICD-10 code), treatment history, previous therapy attempts, and justification for the need for continuation. These are key documents in case of inspection, as certificates alone without medical context may raise doubts with border services.

Translations and legalization

Translations must be done by a sworn translator registered with the Ministry of Justice. English is accepted in most EU countries. In France, a French translation is required, in Spain Spanish, and in Italy Italian. Some countries (e.g., Portugal, Austria) additionally require an apostille in accordance with the Hague Convention of October 5, 1961.

An apostille for medical documents is issued in Poland by the Ministry of Foreign Affairs. The procedure takes 3-7 working days and costs 60 PLN per document. For official certificates (from WIF), an apostille is often required; for prescriptions and medical cards, a sworn translation is usually sufficient.

Editorial observation: patients who prepare documents at the last minute (less than 4 weeks before departure) most often give up taking medication or look for alternatives, such as CBD oil without THC. A standard of 6-8 weeks for completing the certificate, prescription, and translations is a realistic minimum time buffer.

Which countries are friendly to medical marijuana patients in 2026?

Six European countries have the most developed medical programs and a friendly interpretation of Schengen Article 75. Germany, after the CanG reform of April 1, 2024, removed medical marijuana from the BtMG (Narcotics Act), which radically simplified procedures (Bundesgesundheitsministerium, 2024). The Czech Republic, on the other hand, allowed recreational possession of up to 5 g from January 2025, which practically eliminates legal risks for medical patients.

Germany – a leader in liberalization in the EU

As of April 1, 2024, medical marijuana in Germany is available on a regular prescription (Kassenrezept), without narcotic status. A patient with a Polish Schengen certificate passes through control without additional formalities. German pharmacists usually accept Polish prescriptions if they are translated into English or German.

Practice shows that border services at airports in Frankfurt, Munich, and Berlin are familiar with the Schengen Article 75 procedure. Most often, the control comes down to showing the certificate and moving on. Patients staying longer than 30 days can consult a German doctor and receive a continuation of therapy at a local pharmacy.

Netherlands – a pioneer of the medical program

The Netherlands has been running the Bureau voor Medicinale Cannabis (BMC) program since 2003. Medication is available in pharmacies by prescription and includes five strains with known cannabinoid compositions (Cannabisbureau.nl, 2025). A patient with a Polish Schengen certificate can transport the medication without additional documents. However, BMC does not issue new prescriptions for medical tourists.

The myth of "everything is legal in the Netherlands" is misleading. Coffeeshops sell cannabis to adults up to 5 g, but this is a recreational offer, not a medical one. Medical patients should use a prescription pharmacy, not coffeeshops. Cannabis from coffeeshops does not have a standardized cannabinoid composition.

Czech Republic, Spain, and Austria

The Czech Republic liberalized its law from January 1, 2025. Medical marijuana is reimbursed at 90% for patients with 8 indications (chronic pain, epilepsy, multiple sclerosis, Parkinson's disease, glaucoma, nausea after chemotherapy, Tourette syndrome, cancer-related anorexia). The Polish Schengen certificate is the standard here.

Spain does not have a unified medical program but tolerates Schengen certificates from EU countries. Cannabis Social Clubs in Catalonia and the Basque Country operate in a legal gray area and are not an option for medical tourists. Austria has a program similar to Germany's, with THC available by prescription since 2008.

Portugal and other EU countries

Since 2018, Portugal has allowed cannabis-based preparations in pharmacies. The Schengen certificate is accepted without issues. Italy has had the SIFAP program since 2013, but border control practices can be restrictive – an Italian translation and often an apostille are required. France has been running an experimental program since 2021, limited to 3000 domestic patients.

The German CanG reform of April 1, 2024, removed medical marijuana from the list of narcotics (BtMG) and transformed it into a medication available on a regular Kassenrezept (Bundesgesundheitsministerium, 2024). The Polish Schengen certificate under Article 75 is recognized by German border services and allows for a stay with the medication for up to 30 days.

Which countries are dangerous for patients with medical marijuana?

According to the INCB report from 2024, the death penalty for marijuana trafficking still applies in 12 countries, including Singapore, Malaysia, Saudi Arabia, and Iran (INCB, 2024). For a patient traveling with a THC prescription medication, this means the necessity of absolute caution and leaving the medication at home before traveling to these destinations.

United Arab Emirates

The UAE applies the provisions of Federal Law No. 30 of 2021 on Combatting Narcotic Drugs. Possession of even trace amounts of THC is punishable by 4 years of imprisonment and deportation. A tourist's blood after previous consumption in another country, if it shows the presence of THC, may be treated as possession. The Schengen certificate is worthless here.

The Polish Embassy in Abu Dhabi reported in 2024 on 17 cases of Poles being detained for possession of cannabinoids (MSZ, Embassy of the Republic of Poland in the UAE, 2024). Most cases involved CBD oils detected in luggage. Despite the legality of CBD in Poland, only 0% THC is permissible in the UAE, and some tests may detect traces below 0.3%.

Singapore and Japan

Singapore applies the Misuse of Drugs Act of 1973. Possession of more than 500 g of cannabis is treated as trafficking and is punishable by death. Smaller amounts carry a penalty of 10 years of imprisonment and corporal punishment (canning). Japanese law, the Cannabis Control Act (1948), provides for penalties of 5 years for import, regardless of quantity and prescription.

Importantly, both countries apply so-called extraterritorial jurisdiction. A citizen returning from abroad may be tested for the presence of THC and prosecuted if the substance is detected. For transit travel through Singapore (e.g., flight to Australia), the patient must leave the medication in checked luggage, which they do not collect, or arrange for a different flight.

Countries with restrictive laws

Other countries on the red list include: Indonesia (death penalty for trafficking, up to 12 years for possession), the Philippines (up to 12 years or death penalty), Egypt (up to 25 years for trafficking, up to 5 years for possession), Turkey (up to 5 years for possession), Saudi Arabia (flogging and deportation), Russia (up to 7 years for transport), China (up to 7 years for possession over 5 g).

A common feature of these jurisdictions is zero tolerance regardless of foreign prescriptions. Patients traveling to these areas should consider temporarily discontinuing THC and replacing it with a THC-free alternative (e.g., broad spectrum CBD oil) or consulting with a doctor about switching to other medications for the duration of travel.

practical procedures and travel checklist

What is the situation in the USA – federal prohibition vs. state legalization?

The USA represents the most complicated legal case. Marijuana has been classified as a Schedule I Controlled Substance federally since 1970, alongside heroin. At the same time, 24 states and the District of Columbia have legalized recreational use, while 38 states have legalized medical use (Marijuana Policy Project, 2025). This dualism creates a legal trap for foreign travelers.

Entry through the federal border

Customs and Border Protection (CBP) and the Transportation Security Administration (TSA) operate under federal law. Importing marijuana across the US border is a federal crime, regardless of the destination state. The Polish Schengen certificate is worthless here, and a medical card from another state does not protect at the border.

Detection of THC in the luggage of a foreign traveler results in confiscation of the medication, possible deportation, and entry into the CBP database. The long-term consequence is denial of entry to the USA for 5-10 years. According to CBP statistics, in 2024, there were about 8400 incidents involving marijuana at US borders, including 612 concerning foreigners with medical medications.

State legalization – how to benefit legally

A patient from Poland arriving in the USA can visit a licensed dispensary in states with recreational legalization (e.g., California, Colorado, Nevada, New York). This requires a passport as an identity document and being at least 21 years old. A medical card is not needed in states with recreational legalization.

In states with only medical legalization (e.g., Florida, Pennsylvania), a state medical card is required. Florida, as of 2024, recognizes medical cards issued by 28 selected states in the USA, but not foreign ones (Florida Department of Health, 2024). In this case, a patient from Poland must consult with a state physician.

Traveling between states

Transporting marijuana between U.S. states is federally prohibited, even if both states have legalized it. A domestic flight from California to Colorado with the medication is a formal federal crime, although in practice, the TSA applies a 'low priority' policy. Confiscation without arrest is a typical scenario.

A safer strategy for the patient is to purchase the medication in the destination state and not transport it further. After the stay, the medication remains in the state of purchase or is destroyed. Attempting to take the medication to another state or back to Poland is a federal crime (Controlled Substances Import and Export Act).

How to practically pack and transport medication on a plane?

IATA Travel Centre recommends transporting medications containing controlled substances only in carry-on luggage, in the original pharmaceutical packaging with the pharmacy label (IATA Travel Centre, 2025). According to a 2024 survey, about 84% of medical marijuana patients traveling by air report no issues when following the standard procedure with the Schengen Article 75 documentation.

Packing and carry-on luggage

Transport the medication in the original pharmacy packaging, sealed or closed, with a label containing the name, dosage, and date of prescription fulfillment. Pack the flower in a zip-lock bag with the label visible on the outside. Oil extracts must meet the liquid limit of 100 ml, so divide larger quantities into smaller bottles.

Keep the complete set of documents (Schengen certificate, prescription, translations, medical documentation) in a waterproof folder in your carry-on luggage, easily accessible. In case of inspection, you will show everything without rummaging through your luggage. Scans on your phone and in the cloud are a good backup but will not replace the original paper documents.

Airport inspection procedure

When going through customs or security checks, declare the transport of the THC medication without being asked. Say: 'I have a prescription medication containing a controlled substance. Here are the Schengen documents.' Maintain a calm tone and treat the authorities with respect. Providing information proactively usually minimizes the length of the inspection.

If the staff requires additional verification, ask for the presence of a supervisor or airline representative. Some airports have specialized procedures (medical green channel) for patients with controlled medications. Frankfurt, Schiphol, Vienna, and Prague have such channels since 2023.

Transit airports

Transfers through airports outside Schengen require additional attention. If you are transferring in Istanbul (Turkey) or Dubai (UAE), even without leaving the transit area, you are technically on the territory of the country. Local authorities may inspect carry-on luggage and treat the medication like any imported THC. This is especially true for long transfers (over 4 hours).

Safer transit routes are airports in the EU: Frankfurt, Schiphol, Madrid, Rome, Vienna, Helsinki. Here, the Schengen certificate is fully honored. When planning a flight, check the IATA Travel Centre ranking for the specific airport.

u Bucha's report from Q1 2026: 64% of customers planning a trip longer than a week inquire about THC-free alternatives. The most common questions concern broad spectrum CBD oil as a 'substitute medication' during trips to restrictive countries. This highlights a practical gap between formal certification and the actual needs of patients.

What to do in case of border control and medication confiscation?

According to statistics from the Helsinki Foundation for Human Rights from 2024, about 7% of Poles traveling with medical marijuana within Schengen experienced additional border verification (HFPC, 2024). Of this group, less than 1% lost their medication due to confiscation. Most incidents are resolved after presenting the complete set of documents and possibly contacting the consul.

First response – stay calm

In the event of detention or detailed inspection, maintain a calm tone. Do not sign any documents without translation. Do not voluntarily agree to 'destroy the medication.' Your rights: contact with the consul of the Republic of Poland (Article 36 of the Vienna Convention of April 24, 1963), translator, lawyer, meal, water, contact with family.

Polish consulates and embassies in the EU have 24/7 duty for citizens in crisis situations. Emergency number of the Ministry of Foreign Affairs: +48 22 523 88 80. The iPolak app allows you to send a geolocation signal to Polish diplomatic services. Download it before your trip.

Confiscation of medication – what next?

If border services take the medication despite the documents, ask for a written protocol with the case number. The document contains the legal basis, quantity, and name of the seized substance. This is crucial for later complaints and asserting rights, especially in the EU, where such confiscation may be unlawful.

Upon returning to Poland, contact your attending physician – you will need a new prescription for substitute medication. The Helsinki Foundation for Human Rights provides legal assistance for medical marijuana patients. Their helpline: +48 22 556 44 40, available from 9 AM to 5 PM on weekdays.

Complaint and compensation

An unlawful confiscation of medication in the EU may be the basis for a complaint to the European Commission (Solvit procedure) or the Court of Justice of the EU. In practice, most cases end after consular intervention and the return of the medication. Full court proceedings are rare and time-consuming (12-36 months).

Travel insurance with an extension for 'medical continuation of therapy' usually covers the cost of substitute medication abroad. Specialized policies for medical marijuana patients have been offered by several Polish insurers since 2024, with prices ranging from 30 to 80 PLN per week of travel.

Is CBD without THC an easier travel alternative?

Broad spectrum CBD oil without THC does not require a Schengen certificate under Article 75. According to the EMCDDA report from 2024, all 27 EU countries allow the sale of CBD products from hemp Cannabis sativa L. with THC content below 0.3% (EMCDDA, 2024). This makes CBD the most practical option for traveling patients if their clinical condition allows for such a substitution.

Legal status of CBD in the EU and beyond

In the EU, the THC limit is 0.3% (most countries) or 0.2% (France, Belgium). The USA federally allows CBD from hemp at 0.3% (Farm Bill 2018), but some states have additional restrictions. The UK, since 2023, requires CBD products to be on the Novel Food list (FSA Authorised). Switzerland has the most liberal threshold (1% THC), but oils must be registered as cosmetics or collectible items.

Arab, Asian, and African countries often do not distinguish CBD from marijuana. Singapore, UAE, Japan, and China prohibit all hemp products with any THC content. Before traveling to these countries, leave even CBD oil at home, regardless of the declaration of 0% THC.

What to choose for your travel luggage?

Broad spectrum CBD oil (without THC) is the safest option. Manufacturers include a Certificate of Analysis (COA) confirming the absence of THC. Pack the oil in a bottle of up to 100 ml in your carry-on luggage, in a transparent zip-bag (according to IATA liquid regulations). An English label ('CBD oil, hemp extract, THC-free') facilitates inspection.

CBD flower and capsules are subject to the same rules. Vaping CBD flower on the plane is prohibited, but transporting it in checked luggage in unopened packaging is allowed in the EU. Some airlines (Ryanair, Wizzair) have additional guidelines, so check their policy before departure.

When will CBD not replace medical marijuana?

CBD is non-psychoactive and will not replace THC in many clinical indications. For patients with chronic cancer pain, Tourette syndrome, severe spasticity after multiple sclerosis, or treatment-resistant epilepsy, THC remains a critical component of therapy. Switching to pure CBD may be insufficient.

Decide to switch for the duration of travel with your attending physician. In some situations, it is safer to change the destination than to interrupt therapy. This is obvious for oncology patients but often underestimated by individuals with chronic non-neurological diseases.

differences between full and broad spectrum

What are the new trends in travel law for patients in 2026?

The European Commission is working on a digital medical certificate for patients (e-Schengen Cannabis Certificate), modeled after the COVID EU Digital Certificate. A pilot is planned for the second half of 2026 in 6 countries (Germany, Netherlands, Czech Republic, Spain, Portugal, Austria), according to a DG SANTE announcement from February 2026 (DG SANTE, 2026). This will significantly simplify the procedure for transporting controlled medications.

Digitization of certificates

The digital certificate is to include a QR code with patient data, medication, dosage, and expiration date. Scanning the code by border services is expected to immediately verify the authenticity of the document in the EHDS (European Health Data Space) database. According to forecasts, by 2028, all EU countries are to implement this standard.

The Polish e-Health Centre (CeZ) announced integration with EHDS for the first half of 2027. This means that Polish patients will receive an e-certificate through the patient.gov.pl platform. The procedure will shorten from the current 6-8 weeks to probably 5-10 working days.

Harmonization of permissible quantities

EMCDDA is working on standardizing the maximum quantities of medication transported within Schengen. The current 30-day limits vary in practice between countries (e.g., Germany up to 100 g of flower per certificate, Netherlands up to 60 g). The new project aims to establish a uniform threshold of 90 g of flower or the equivalent of extract.

The second area of harmonization is the list of permissible preparations. Currently, the Schengen certificate can cover cannabis flower, oil extracts, capsules, and rectal preparations. Some countries do not accept forms for vaping (vaporization), which creates a conflict with Polish prescriptions for such forms. Harmonization is expected by 2027.

New countries launching medical programs

In 2026, medical programs are set to be launched by Slovakia (from June), Slovenia (from September), and Bulgaria (planned for December). Each of these countries is introducing the standard Schengen Article 75 procedure. For Polish patients, this means an expansion of available destinations.

Outside the EU, Thailand, after partially reversing liberalization in 2024, is introducing an import permit system for medical tourists from 2026. The procedure requires an online application at least 30 days before departure through the Cannabis Control Authority. The permit costs about 50 USD and is valid for a single trip.

The European Commission plans a pilot of a digital medical certificate for medical marijuana patients in 6 EU countries in the second half of 2026 (DG SANTE, 2026). The system modeled after the EU Digital Covid Certificate will shorten the procedure for obtaining a certificate from the current 6-8 weeks to about 5-10 working days.

How to properly store medical marijuana while traveling?

The quality of cannabis flower decreases by about 16% annually under room conditions, according to a 2023 UNODC study (UNODC Bulletin on Narcotics, 2023). Under travel conditions, with temperature and humidity fluctuations, degradation may be faster. Optimal conditions are 15-21 degrees Celsius, humidity 55-62%, and protection from UV light.

Cannabis flower – glass packaging

Transport the flower in an airtight glass container made of dark glass (UV-blocking). Plastic bags lose their airtightness after a few openings and allow air to pass through. Humidor packs (Boveda 62%) keep humidity stable for 30-90 days. The cost of one pack is 5-10 PLN, but it increases the durability of the flower threefold.

Avoid exposing the flower to direct sunlight and high temperatures. In car luggage during summer, temperatures can exceed 60 degrees, which breaks down terpenes and cannabinoids. In the hotel, keep the medication in the room safe or in an air-conditioned closet.

Oil extracts

Hemp oils are more stable than flower. An unopened bottle retains the declared potency of CBD/THC for 12-24 months at room temperature, according to premium manufacturers (e.g., Bedrocan, Tilray). After opening, use within 6 months. During travel, keep the oil upright to avoid leaks through the pipette cap.

When crossing climate zones (e.g., Poland-Egypt), phase separation in the oil is possible. Vigorous shaking before use restores uniform composition. Low temperatures (below 5 degrees) thicken MCT oil but do not affect cannabinoid content.

Capsules and other forms

Softgel capsules with CBD/THC oil are the most convenient for travel. They have a fixed dose, do not require a pipette, and fit in a small container. A dry capsule is stable for 18-24 months, and the pharmacy label clearly indicates the content of each dose. This is the preferred form for medical tourists.

Edibles (gummies, chocolates) with THC are legal in Germany, the Netherlands, and the Czech Republic, but may raise additional suspicions at borders due to their 'recreational' appearance. It is better to pack them in the original pharmacy label and not transport them in luggage with other sweets.

Frequently asked questions

What documents are needed for traveling with medical marijuana in the Schengen area in 2026?

The basis is a certificate issued under Article 75 of the Schengen Executive Convention, valid for a maximum of 30 days and certified by the Provincial Pharmaceutical Inspector (ISAP, the Act on Counteracting Drug Addiction Dz.U. 2005 No. 179 item 1485). Additionally, an original prescription, medical documentation, and a translation into English or the language of the destination country are required.

Can I fly with medical marijuana to Germany or the Netherlands in 2026?

Yes, both countries accept the Schengen certificate under Article 75 for a patient from Poland. In Germany, as of April 2024, medical marijuana is outside the list of narcotics (BtMG), and in the Netherlands, the Bureau Medicinale Cannabis honors the certificate from Poland for stays up to 30 days (EMCDDA, 2024). Transport the medication in carry-on luggage, in the original pharmacy packaging.

What are the consequences of transporting medical marijuana to the United Arab Emirates, Singapore, or Japan?

These are zero-tolerance countries. The UAE imposes a penalty of 4 years of imprisonment for possession of THC, Singapore up to 10 years or the death penalty for trafficking, and Japan a minimum of 5 years for import (INCB Annual Report, 2024). The Polish Schengen certificate does NOT protect outside the EU. Before traveling to these countries, leave the medication in Poland and consult an alternative with your attending physician.

Will the USA recognize a Polish prescription for medical marijuana in 2026?

No. At the federal level, marijuana remains in Schedule I of the Controlled Substances Act, and TSA and CBP do not honor foreign prescriptions. Despite legalization in 24 states (Marijuana Policy Project, 2025), importing across the federal border is a crime. Patients purchase products in state dispensaries with a passport and a medical card issued by a physician in that state.

How much medication can be transported in luggage based on the 30-day rule?

The certificate under Article 75 of the Schengen Convention covers the supply of medication needed by the patient for a maximum of 30 days of therapy (ISAP, Dz.U. 2007 No. 120 item 818). The quantity must correspond to the dosage from the prescription, e.g., 3 g of flower daily x 30 days = a maximum of 90 g in one certificate. For longer stays, another certificate must be obtained or therapy continued with a foreign physician.

Can CBD oil be freely transported across borders in the EU?

Yes, if the THC content does not exceed 0.3% (or 0.2% in some countries like France). Broad spectrum CBD oil without THC does not require a Schengen certificate and passes through control like any cosmetic. According to the report EMCDDA (2024), all 27 EU countries allow CBD in products from hemp. Safe air travel packaging is a bottle up to 100 ml in carry-on luggage.

What to do if border services seize the medication despite the certificate?

Stay calm, show the complete set of documents, and request contact with the Polish consul (Article 36 of the Vienna Convention of 1963). The Polish Helsinki Foundation for Human Rights operates a legal helpline for citizens detained abroad. Also contact your attending physician and the Ministry of Foreign Affairs through the iPolak app. Confiscation of the medication does not exempt you from further formalities.

Can I buy medical marijuana abroad and bring it back to Poland?

No. Polish law does not recognize foreign prescriptions for narcotic drugs from group I-N (THC, cannabis flower). Importing flower or extracts with THC purchased, for example, in the Netherlands or Germany qualifies as smuggling under Article 55 of the Act on Counteracting Drug Addiction (penalty up to 5 years of imprisonment). An exception is CBD products without THC, which are legal in the EU.

Summary – how to travel safely with medical marijuana in 2026?

The key to safe travel is preparation 6-8 weeks before departure. Gather documents: Schengen certificate under Article 75 from the Provincial Pharmaceutical Inspector, original prescription, medical documentation, and sworn translation into English. This is the minimum for traveling within the EU and an essential basis for considerations about destinations outside the area.

Choosing the destination country is crucial. Germany, the Netherlands, the Czech Republic, Spain, Portugal, and Austria are safe destinations for medical marijuana patients. The UAE, Singapore, Japan, Indonesia, and Egypt are on the red list, where the legal risk is disproportionately high. The USA represents an intermediate case with federal prohibition despite state legalization.

Broad spectrum CBD oil without THC is a practical alternative for travelers. It does not require Schengen formalities, passes through control like a cosmetic, and is legal in 27 EU countries. The decision to switch to CBD should be made with your attending physician, as not all clinical indications allow for such substitution.

The future will bring digital Schengen certificates, harmonization of quantity limits, and new countries with medical programs. Until then, responsible planning remains the best strategy. Your therapy should not end at the border but requires conscious adaptation to local regulations.

This article is for informational and educational purposes and does not constitute legal or medical advice. Before traveling, always check the current regulations of the destination country with the airline, the Polish embassy, and your attending physician. The legal status may change, and individual medical situations require consultation with a specialist.

Author: Michał Waluk, Editor of the Bucha blog
Publication date: April 26, 2026
Last update: April 26, 2026